Camden Capital »

Ultragenyx Pharmaceutical shares owned by Camden Capital

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Camden Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $437k 9.1k 47.82

More positions owned by Camden Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Wisdomtree Tr Floatng Rat Trea (USFR)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Exxon Mobil Corporation (XOM)
General Electric Com New (GE)
New York Community Ban (NYCB)
Citigroup Com New (C)
Micron Technology (MU)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Chevron Corporation (CVX)
Bank of America Corporation (BAC)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)

View all positions for Camden Capital

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
Wellington Management Company
T. Rowe Price Associates
Federated Investors
ClearBridge Advisors
Alliancebernstein
Marshall Wace
Baker Bros. Advisors
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Avidity Partners Management
Norges Bank Investment Management
First Light Asset Management
Jacobs Levy Equity Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Ultragenyx Pharmaceutical